GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company says new ...
Abstract: This communication proposes a dual-linear polarized 2-bit reconfigurable transmitarray (DLPRTA) operating at Ku-band. The independent dual-linear polarization unit cell consists of two ...
Abstract: In today’s digital era, where information flows seamlessly and is readily available and accessible. However, these information and communication systems are highly dependent on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results